Menopausal Hormone Therapy, an Ever-Present Topic: A Pilot Survey about Women’s Experience and Medical Doctors’ Approach
Author:
Aquino Carmen Imma1ORCID, Stampini Viviana1ORCID, Osella Elena1, Troìa Libera1ORCID, Rocca Clarissa2, Guida Maurizio3ORCID, Faggiano Fabrizio4ORCID, Remorgida Valentino1ORCID, Surico Daniela1
Affiliation:
1. Department of Translational Medicine, University of Piemonte Orientale, Gynecology and Obstetrics, “Maggiore della Carità” Hospital, 28100 Novara, Italy 2. Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy 3. Department of Neurosciences and Reproductive Sciences, University of Naples Federico II, 80131 Naples, Italy 4. Department for Sustainable Development and Ecological Transition, University of Piemonte Orientale, 13100 Vercelli, Italy
Abstract
Background and Objective: Menopause can be associated with many clinical manifestations: vasomotor symptoms, urogenital problems, and additional psychological disturbances, such as anxiety, mood changes, and sleep alterations. The prolonged lack of hormones also increases the risk of long-term consequences. Hormone Replacement Treatment (HRT) in menopause consists of the administration of estrogen, alone or associated to progesterone, to relieve these uncomfortable disturbances and to prevent the onset of other pathologic conditions. The aim of this study is to examine the prevalence of HRT use in a sample of menopausal women and their experience with menopause and HRT. This study also investigates the knowledge of general practitioners (GPs) and gynecologists about HRT and its prescription. Materials and Methods: We conducted a cross-sectional population survey on 126 women of 50–59 years in an industrial city in the North of Italy, Vercelli (Novara), in Eastern Piedmont. We also presented a questionnaire on the topic to 54 medical doctors (GPs and gynecologists) of the same area. Results: The prevalence of HRT use in our sample was 11.9%. In total, a good percentage of the users affirmed to be satisfied with HRT. Additionally, a minority of women reported being ideally against the use of replacement hormones, were advised against using HRT by doctors, and did not use it because of the fear of side effects. We found a positive association between patient education, health care attitude, and HRT usage. A significant number of women knew about HRT from the media, and most of them were not informed by a health professional. Despite this, the interviewed doctors considered their knowledge about HRT as ‘good’ and would recommend HRT: only 5.6% would not prescribe it. Conclusions: Our results highlight the need for information about HRT among patients and health professionals, along with the need for more effective communication, evaluation, and suggestion of treatment.
Reference34 articles.
1. Menopause;Nelson;Lancet,2008 2. The menopause transition and women’s health at midlife: A progress report from the Study of Women’s Health Across the Nation (SWAN);Greendale;Menopause,2019 3. The Menopause Transition: Signs, Symptoms, and Management Options;Santoro;J. Clin. Endocrinol. Metab.,2021 4. Academic Committee of the Korean Society of Menopause, Lee, S.R., Cho, M.K., Cho, Y.J., Chun, S., Hong, S.H., Hwang, K.R., Jeon, G.H., Joo, J.K., and Kim, S.K. (2020). The 2020 Menopausal Hormone Therapy Guidelines. J. Menopausal Med., 26, 69–98. 5. Bone Health During the Menopause Transition and Beyond;Karlamangla;Obstet. Gynecol. Clin. N. Am.,2018
|
|